Subscribe to Newsletter

Business & Regulation

 Business & Regulation Profession

Funding Pharma’s All-Female Leaders

| Martino Picardo | 4 min read

In Britain and around the world, the investment ecosystem dominated by males needs an urgent shake up.

Business & Regulation Business Practice

Social Media Reacts to Eli Lilly’s Price Reduction of Insulin

| Stephanie Sutton | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?
Business & Regulation Digital Technologies

Video: Matthew Lakelin on Improving Supply Chain Efficiency

| Rob Coker

A video interview covering supply chain improvement technology
Business & Regulation Digital Technologies

Entering the Modern Era for Data-Driven Quality Control

| Jason Boyd, Simon Meffan-Main | 4 min read

A new class of modern cloud systems promises the next step change in QC productivity and data integrity.
Business & Regulation Profession

No One Left Behind

| Stephanie Sutton | 10 min read

We speak with Eric Dube, CEO of Travere Therapeutics, about his career and thoughts on leadership.
Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?
Business & Regulation Business Practice

A Roadmap to Greener Pharma Logistics

| Julius Graf von Pfeil, Kees Schmidt | 10 min read

How to make the art of pharmaceutical logistics more sustainable.

Business & Regulation Profession

Hybrid Theory

| Angus Stewart | 8 min read

Industry experience needn’t always come post-academia – other options are available, as we learned in our chat with this Northern Irish PhD candidate
Business & Regulation Marketing

Video: Kim Barnes on Post-Pandemic Pharma Events

| Stephanie Sutton

A video interview tackling the post-pandemic challenges of the events industry
Business & Regulation Business Practice

Focusing on Sustainability

Download our eBook to find out how the industry is trying to be more sustainable.

Business & Regulation Trends & Forecasts

Weathering the Storm: Cell and Gene’s Economic Downturn

| James Wilson, Anshul Mangal | 5 min read

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?
Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Sutton | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.
Business & Regulation Business Practice

A Contentious Issue

| Stephanie Sutton | 4 min read

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker